Syntegra and the Institute for Health Metrics Expand Strategic Partnership to Bring Privacy-Assured Health Data to the Life Sciences


SAN FRANCISCO, October 18, 2022 /PRNewswire/ — Syntegraa leader in the generation of synthetic data, and the Health Metrics Institute (IHM), the nonprofit hospital data collaboration, today announced an expanded partnership to enable easier and faster access to millions of privacy-assured electronic health records for life sciences companies. life.

This strategic partnership combines the privacy-preserving capabilities of Syntegra’s synthetic data engine with IHM’s extensive data repository to provide access to high-fidelity patient-level data that would otherwise not be available. Organizations can access more granular data and share it more widely without the privacy risk of protected health information. This unprecedented level of data access enables the life sciences industry to drive innovation and accelerate the development of new treatments for patients.

EHR data is representative of 7 million patients in healthcare systems across the United States, spans a five-year period, and includes a full and diverse range of patient demographics and therapeutic areas. Notably, this data also includes social determinants of health variables (such as housing and food insecurity), as well as timestamps.

Pharmaceutical organizations can leverage this synthetic data offering to quickly understand the data and improve the design of their RWE and HEOR studies with fewer hurdles. They can then supplement real data with synthetic data to expand rare or underrepresented populations for deeper analyses, leveraging Syntegra’s personalization capabilities.

“Our partnership with Syntegra combines clinical data from HMI with Syntegra’s world-class synthetic data manufacturing technology, enabling many other users to benefit from the information available from protected health information without the risk of mismanagement. of PHI,” said Tom Gather, COO of HMI. “We look forward to working with the Syntegra team to set the standard for realistic, risk-free clinical data at scale.”

“We are thrilled to extend our partnership with IHM,” said Michael D. Lesh, SM MD FACC, Founder and CEO of Syntegra. “Together, we are opening up access to millions of patient records with an unprecedented level of privacy protection, enabling innovation in healthcare.”

About Syntegra
Syntegra unlocks the promise of real-world evidence by using a revolutionary transformer-based generative model – the Syntegra Medical Mind – to enable low-cost access to fair, privacy-protected synthetic health data, increasing the value of data for those who have and giving access to those who need it. Synthetic data is the statistical accuracy of the underlying data unrelated to actual patients, fully protecting patient privacy. Syntegra’s ever-evolving model is built from the statistical models of structured health data to meet the diverse needs of our customers, including health systems, life science companies, health technologies, payers and clinical research organizations. Get immediate access to patient-level data through our Synthetic Data API today. Learn more about and follow us on LinkedIn and Twitter.

About the Institute of Health Metrics
For more than a decade, the Institute for Health Metrics (IHM) has been an innovator in the use of real-world data (RWD) in healthcare research, creating the first meaningful use reporting system SaaS and a purpose-built, HIPAA-compliant system. , cloud data repository. IHM data – including detailed clinical details as well as unstructured notes for outcome study and comparative effectiveness – represents community hospitals everywhere United States, a unique population often underrepresented in the medical literature and clinical trials. HMI enables healthcare organizations to achieve better results through the use of better data. For more information, visit or contact [email protected].

Contact Syntegra:
Lauren McQuatters
[email protected]

Health Metrics Institute
Tom Gather
[email protected]



Comments are closed.